TheraRadar
← Back
Data updated: Mar 29, 2026

SUNSHINE

DermatologyInfectious DiseaseRespiratory
Generics

SUNSHINE is a generic drug manufacturer focused on Dermatology, Infectious Disease, Respiratory.

2018
Since
25
Drugs
-
Trials
374
Approved (2yr)

Key Drugs

LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
linagliptin
Metabolic
DPP-4 1 indications · 2021

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

BRIVARACETAM 2026-02-23
BRIVARACETAM 2026-02-23
BRIVARACETAM 2026-02-23
BRIVARACETAM 2026-02-23
BRIVARACETAM 2026-02-23
BRIVARACETAM 2026-02-23
BRIVARACETAM 2026-02-23
BRIVARACETAM 2026-02-23
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Dermatology 25%
3 drugs Phase 3: 6 Phase 2: 1 Phase 1: 4
Infectious Disease 24%
3 drugs Phase 3: 1 Phase 2: 5 Phase 1: 14
Respiratory 21%
3 drugs Phase 3: 3 Phase 2: 3 Phase 1: 5
Oncology 18%
0 drugs Phase 3: 3 Phase 2: 3 Phase 1: 17
Cardiovascular 12%
4 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Baxter specialty
Infectious Disease, Cardiovascular, Oncology, Dermatology
Pfizer big-pharma
Oncology, Infectious Disease, Dermatology
COSETTE other
Cardiovascular, Dermatology, Infectious Disease, Oncology
Novartis big-pharma
Oncology, Cardiovascular, Respiratory
GE HEALTHCARE specialty
Infectious Disease, Cardiovascular, Oncology, Respiratory